INS and diabetes mellitus: In middle-aged adults with both diabetic and non-diabetic histories, insulin-sensitizing TZD compounds improve insulin sensitivity and glucose tolerance, and increase the likelihood of regression from pre-diabetes to normal glucose regulation [199,200].